Skip to main content

Table 1 Comparison of demographic and serological parameters used in this study

From: Increased levels of anti-glycan antibodies in patients with cystic fibrosis

Parameter CF (n = 119) CD (n = 34) UC (n = 11) RA (n = 22) HC (n = 16) p < 0.05
Gender (m/f) 67/52 14/20 3/8 5/17 10/6 n.s.
Age 23.0 36.5 30.0 57.5 29.0 RA vs. all
(years) [16, 33]* [29, 58] [25, 61] [49, 64] [28, 34]  
WBC 8.9 8.5 8.5 8.0 n.d. n.s.
(/nl) [7, 11] [5, 10] [6, 11] [6, 11]   
CRP 0.3 0.4 0.3 0.3 n.d. n.s.
(mg/dl) [0.1, 1.0] [0.1, 1.2] [0.05, 1,0] [0.1, 3.9]   
ALCA 18.8 30.8 16.3 14.3 23.3 CD vs. RA
(U/ml) [12, 32] [21, 50] [12, 29] [9, 20] [19, 31]  
ACCA 22.2 35.4 30 24.1 35.6 n.s.
(U/ml) [17, 39] [22, 47] [16, 40] [17, 31] [27, 42]  
AMCA 29.9 32.8 23.1 23.8 30.6 n.s.
(U/ml) [23, 46] [25, 55] [16, 26] [20, 30] [20, 40]  
gASCA 55.6 88.9 20.5 20.0 23.0 CD vs.
(U/ml) [27, 124] [51, 14.3] [15, 40] [14, 27] [10, 38] CU, RA, HC
  1. Continuous variables: median [Q25%, Q75%], WBC = white blood cell count; CRP = C-reactive protein; CF = cystic fibrosis; CD = Crohn's disease; UC = ulcerative colitis; RA = rheumatoid arthritis; HC = healthy volunteers. Differences between groups were compared by ANOVA with Scheffe-Test or Fisher's exact test(*) with Bonferroni.